Novo's Obesity Drug Shows Promising Results

Novo has released new evidence that its experimental CagriSema injection can significantly improve weight loss in women, potentially outperforming its blockbuster GLP-1 obesity drug, Wegovy. The findings could have major implications for the treatment of obesity.